Compound: Crizotinib

Drug Target: MET, ALK, ROS1

Drug Target pathway: RTK signaling

Dataset


Tissue specific analysis

Contact us | Cookies policy | Terms & Conditions. This site is hosted by the Wellcome Sanger Institute.